The role of chronic obstructive pulmonary disease in acute coronary syndrome patients: a critical risk factor for lipid plaque burden?

2021 ◽  
Vol 69 (6) ◽  
Author(s):  
Francesco PIROLI ◽  
Antonio M. LEONE ◽  
Simone CALCAGNO
2021 ◽  
Vol 13 (1) ◽  
Author(s):  
John Charles Rotondo ◽  
Giorgio Aquila ◽  
Lucia Oton-Gonzalez ◽  
Rita Selvatici ◽  
Paola Rizzo ◽  
...  

Abstract Background Diagnostic biomarkers for detecting chronic obstructive pulmonary disease (COPD) in acute coronary syndrome (ACS) patients are not available. SERPINA1, coding for the most potent circulating anti-inflammatory protein in the lung, has been found to be differentially methylated in blood cells from COPD patients. This study aimed to investigate the methylation profile of SERPINA1 in blood cells from ACS patients, with (COPD+) or without COPD (COPD−). Methods Blood samples were from 115 ACS patients, including 30 COPD+ and 85 COPD− according to lung function phenotype, obtained with spirometry. DNA treated with sodium bisulfite was PCR-amplified at SERPINA1 promoter region. Methylation analysis was carried out by sequencing the PCR products. Lymphocytes count in ACS patients was recorded at hospital admission and discharge. Results SERPINA1 was hypermethylated in 24/30 (80%) COPD+ and 48/85 (56.5%) COPD− (p < 0.05). Interestingly, at hospital discharge, lymphocytes count was higher in COPD− patients carrying SERPINA1 hypermethylated (1.98 × 103 ± 0.6 cell/µl) than in COPD− carrying SERPINA1 hypomethylated (1.7 × 103 ± 0.48 cell/µl) (p < 0.05). Conclusions SERPINA1 is hypermethylated in blood cells from COPD+ patients. COPD− carrying SERPINA1 hypermethylated and high lymphocytes count may be at risk of COPD development. Therefore, SERPINA1 hypermethylation may represent a potential biomarker for predicting COPD development in ACS patients.


Pharmateca ◽  
2020 ◽  
Vol 14_2020 ◽  
pp. 74-80
Author(s):  
B.G. Iskenderov Iskenderov ◽  
N.V. Berenshtein Berenshtein ◽  
T.V. Lokhina Lokhina ◽  
I.N. Mozhzhukhina Mozhzhukhina ◽  

2010 ◽  
Vol 33 (4) ◽  
pp. 228-235 ◽  
Author(s):  
Hadi A. R. Hadi ◽  
Mohammed Zubaid ◽  
Wael Al Mahmeed ◽  
Ayman A. El-Menyar ◽  
Mustafa Ridha ◽  
...  

2021 ◽  
Vol 4 (14) ◽  
pp. 01-05
Author(s):  
Ranjit Sharma ◽  
Anish Hirachan ◽  
Milan Gautam

Background: This study was designed to evaluate the patterns of coronary artery disease in patients with chronic obstructive pulmonary disease (COPD) presenting with the acute coronary syndrome (ACS). Methods: This was a prospective, observational study, conducted on 69 patients with chronic obstructive pulmonary disease, presenting with acute coronary syndrome undergoing coronary angiogram from September 2017 to March 2021. All patients had undergone coronary angiogram; severity and morphology of lesion as well as the severity of calcium were analyzed. Results: The study showed that 69 patients with COPD who presented with ACS, 58.8% of patients were presented with NSTEMI, 30.2% STEMI and Unstable angina 11%. The average time of presentation after the onset of the symptom was 17.6 hours. 64% of patients were a smoker. Coronary involvement 10% of patients had LM, 50% TVD, 30% DVD, and 10% had SVD. Type a coronary lesion was seen in 5%, Type B in 20%, and Type C in 75% of patients. Mild Coronary calcium was seen in 25%. Moderate calcium was in 40% and severe calcium in 35%. Conclusions: COPD patients presenting with ACS, associated with increased severity of coronary calcium and coronary lesions.


Sign in / Sign up

Export Citation Format

Share Document